Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2020-09-30 Share Issue/Capital Cha…
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Orphazyme publishes a prospectus regarding listing of 7,616,146 new ordinary shares on Nasdaq Copenhagen in connection with a global offering
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement from Orphazyme A/S regarding the publication of a listing prospectus for new ordinary shares. It explicitly states that the purpose of the announcement is to inform the market about the publication of this prospectus and the admission of shares to trading on Nasdaq Copenhagen. Following the 'Menu vs Meal' rule, this is an announcement of a report (the prospectus) rather than the prospectus itself, and it fits the definition of a Report Publication Announcement (RPA).
2020-09-30 English
Stabilization period begins
Regulatory Filings Classification · 95% confidence The document is a company announcement from Orphazyme A/S regarding the commencement of a stabilization period following a global offering of American Depositary Shares and Ordinary Shares. It details the stabilization agents, the stabilization period dates, and the over-allotment facility. This type of regulatory disclosure regarding market stabilization activities during or after an offering is best classified as a Regulatory Filing (RNS) as it does not fit into specific categories like M&A, Earnings, or Share Issues, but serves as a formal market notification.
2020-09-29 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 95% confidence The document is a formal company announcement from Orphazyme A/S regarding the commencement of the stabilization period following a Global Offering (IPO/concurrent private placement). It details the stabilizing manager (BofA Securities, Inc.), the securities involved (ADSs and Ordinary Shares), the offer price, and the expected stabilization timeline, referencing EU Market Abuse Regulation. This type of announcement, which relates to the mechanics of a recent capital raise or offering, is most closely related to financing activities. While it is a regulatory announcement, the specific subject matter—stabilization following an offering—falls under the scope of Capital/Financing Update (CAP) as it directly relates to the post-offering market support mechanism for newly issued shares. It is not a general regulatory filing (RNS) because it is highly specific to a capital event, nor is it a full report (10-K, IR).
2020-09-29 English
Orphazyme prices its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement from Orphazyme regarding the pricing of a global offering (IPO of ADSs in the U.S. and private placement in Europe). It details the share price, gross proceeds, capital increase, and the expected timetable for the offering. While it discusses capital, it is specifically an announcement of a share issuance and capital change, which aligns with the 'Share Issue/Capital Change' (SHA) category. It is not a prospectus itself, but an announcement of the offering's pricing and terms.
2020-09-29 English
Share Issue/Capital Change 2020
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Orphazyme prices its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe' and details the pricing, gross proceeds, capital increase authorization, and expected timetable for a global offering (IPO/private placement). This clearly relates to fundraising and capital structure changes. The filing type 'Capital/Financing Update' (CAP) is the most appropriate classification. Although it mentions the SEC filing (F-1 registration statement), the core content is the announcement of the pricing and structure of the capital raise, not the final prospectus itself. The document length (13,422 chars) is substantial enough to be the primary announcement rather than just a brief RPA.
2020-09-29 English
Orphazyme A/S provides update on previously announced global offering
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding an update to a global offering of securities, including details on pricing, timing, and SEC registration filings. While it mentions a registration statement (Form F-1), the document itself is a press release/announcement issued by the company to inform the market about the status of the offering. It does not constitute the registration statement itself, but rather an update on the process. Therefore, it falls under the 'Capital/Financing Update' category as it pertains to the company's fundraising and capital structure activities.
2020-09-25 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.